European Healthtech startup funding raised during March 2025.
In March 2025, 33 European Healthtech companies raised a combined €804M across 33 funding rounds, up 272.7% versus March 2024. UK led by capital raised, and Eli lilly and company was the most active investor. Data as of 23 Aug 2026.
3 exits.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Isomorphic Labs | Other | Mar 2025 | €555M |
| Maxion Therapeutics | Series A | Mar 2025 | €66M |
| Trimtech Therapeutics | Seed | Mar 2025 | €29M |
| Perfuze | Other |
| Mar 2025 |
| €22M |
| Valo Therapeutics | Other | Mar 2025 | €19M |
| Brainomix | Series C | Mar 2025 | €17M |
| Strolll | Series A | Mar 2025 | €12M |
| Jutro Medical | Series A | Mar 2025 | €12M |
| Neuromod Devices | Series B | Mar 2025 | €10M |
| Vantis | Series A | Mar 2025 | €10M |
| Osivax | Series B | Mar 2025 | €9.5M |
| BioCopy | Other | Mar 2025 | €8.0M |
| HelloBetter | Other | Mar 2025 | €6.0M |
| Eventum Orthopaedics | Other | Mar 2025 | €4.5M |
| Irisbond | Other | Mar 2025 | €4.5M |
